Citation Impact
Citing Papers
Human cerebral organoids recapitulate gene expression programs of fetal neocortex development
2015 StandoutNobel
Enzastaurin, a Protein Kinase Cβ Inhibitor, Suppresses Signaling through the Ribosomal S6 Kinase and Bad Pathways and Induces Apoptosis in Human Gastric Cancer Cells
2008
Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq
2015 StandoutScience
Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei
2004 Standout
Loss of NFIX Transcription Factor Biases Postnatal Neural Stem/Progenitor Cells Toward Oligodendrogenesis
2015
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
2009 StandoutNobel
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine
1993
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Epigenetics: A Landscape Takes Shape
2007 Standout
Chronic myelogenous leukemia in nonlymphoid blastic phase
1999
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents
2000
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine
2001
Structure and function of the blood–brain barrier
2009 Standout
TGF-β signalling-related markers in cancer patients with bone metastasis
2008
Epigenetic therapy of cancer: past, present and future
2006
Prodrug Strategies in Anticancer Chemotherapy
2007
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Paclitaxel (Taxol)
1995 Standout
Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer
2004 Standout
Deep-sea natural products
2008
Epigenetics in Cancer
2008 Standout
Pancreatic Adenocarcinoma
2014 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
2021 Nature
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Global cancer statistics
2011 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies
2008
Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology
2012
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010
2011
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Platelet-derived growth factor (PDGF) and glial tumorigenesis
2005
Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic Implications
2013
Malignant Gliomas in Adults
2008 Standout
Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
1993
Inhibiting kinases in malignant gliomas
2007
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Functional organization of the hippocampal longitudinal axis
2014 StandoutNobel
Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals
2008
Breast Cancer in Limited-Resource Countries: Health Care Systems and Public Policy
2006
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
AKT/PKB Signaling: Navigating the Network
2017 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Global trends in breast cancer incidence and mortality 1973–1997
2005
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Guideline implementation for breast healthcare in low-income and middle-income countries
2008
Metabolites from symbiotic bacteria
2008
The molecular neurobiology of depression
2008 StandoutNature
A glucose derivative as natural alternative to the cyclohexane‐1,2‐diamine ligand in the anticancer drug oxaliplatin?
2007
Bisphosphonate conjugation for bone specific drug targeting
2018
Head and Neck Cancer
2001 Standout
Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention
2009
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Inhibition of DNA Synthesis by a Platinum–Acridine Hybrid Agent Leads to Potent Cell Kill in Nonsmall Cell Lung Cancer
2011
Genomic–anatomic evidence for distinct functional domains in hippocampal field CA1
2009
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.
1996 StandoutNobel
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides
1992
The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource‐Stratified Phased Implementation: Methods and overview
2020
Kaposi sarcoma trends in Uganda and Zimbabwe: A sustained decline in incidence?
2013
Comparative biodistribution of thin‐coated iron oxide nanoparticles TCION: Effect of different bisphosphonate coatings
2001
Activation of the p53 DNA Damage Response Pathway after Inhibition of DNA Methyltransferase by 5-Aza-2′-deoxycytidine
2001
18F, 64Cu, and 68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer
2009
Emerging Targets in Photopharmacology
2016 StandoutNobel
Global cancer statistics, 2012
2015 Standout
KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment
2016
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
EAT-4, a Homolog of a Mammalian Sodium-Dependent Inorganic Phosphate Cotransporter, Is Necessary for Glutamatergic Neurotransmission inCaenorhabditis elegans
1999 StandoutNobel
Works of Gilberto Schwartsmann being referenced
In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.
1990
Systemic treatment of AIDS-related Kaposi sarcoma: Current status and perspectives
2006
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies
2006
Treatment of Breast Cancer in Countries with Limited Resources
2003
A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer
2000
Marine-derived anticancer agents in clinical trials
2003
Breast cancer in Latin America
2008
Overview of Breast Health Care Guidelines for Countries with Limited Resources
2003
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
2007
EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models
1993
Current and emerging molecular targets in glioma
2010
Anticancer drug screening and discovery in the 1990s: a European perspective
1993
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
2008
Phase II Trial of Cisplatin Plus Decitabine, a New DNA Hypomethylating Agent, in Patients With Advanced Squamous Cell Carcinoma of the Cervix
2002
Gastrin-Releasing Peptide Receptor as a Molecular Target for Psychiatric and Neurological Disorders
2006
Multidrug resistance gene expression during the murine ontogeny
2001
Sequence-dependent growth inhibition and DNA damage formation by the irinotecan–5-fluorouracil combination in human colon carcinoma cell lines
1999
Essential drugs for cancer therapy: A World Health Organization consultation
1999
Marine organisms as a source of new anticancer agents
2001
Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observations.
1997
A study of the delivery-targeting concept applied to antineoplasic drugs active on human osteosarcoma. I. Synthesis and biological activity in nude mice carrying human osteosarcoma xenografts of gem-bisphosphonic methotrexate analogues
1992
Glioma Revisited: From Neurogenesis and Cancer Stem Cells to the Epigenetic Regulation of the Niche
2012
Targeting Protein Kinase C: New Therapeutic Opportunities Against High-Grade Malignant Gliomas?
2002
Anti-tumour Screening of Brazilian Plants
2002
Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils
2011
Phase I and pharmacokinetic study of rhizoxin.
1992
von Willebrand factor antigen levels in plasma of patients with malignant breast disease
2001
Breast cancer in South America: challenges to improve early detection and medical management of a public health problem.
2001
Anti-Cancer Drug Discovery and Development in Brazil: Targeted Plant Collection as a Rational Strategy to Acquire Candidate Anti-Cancer Compounds
2000